SF3591
IntroducedMNCannabis concentrate, cannabis flower, topical, or transdermal hemp products THC potency limits establishment and retail location and product labeling requirements provisions
Minnesota · Session 2025
Status
Introduced
As of Feb 17, 2026
Last Action
Introduction and first reading
Official Source
Official Full Bill TextSummary
A Minnesota bill introduced for first reading would establish THC potency limits for cannabis concentrates, flower, topical, and transdermal hemp products, and set retail location and product labeling requirements. Potency caps and labeling mandates could require retailers to reformulate or discontinue certain products and update packaging, while cultivators may face restrictions on marketable product types.
What
A Minnesota bill introduced for first reading would establish THC potency limits for cannabis concentrates, flower, topical, and transdermal hemp products, and set retail location and product labeling requirements.
Who
retailers and cultivators and manufacturers
Why
Potency caps and labeling mandates could require retailers to reformulate or discontinue certain products and update packaging, while cultivators may face restrictions on marketable product types.
Want to advertise here?
Get your business listed on buyweed.us
Want to advertise here?
Get your business listed on buyweed.us
More Minnesota Cannabis Bills
- SF4401Omnibus Cannabis billPassed
- SF4957Registered designated caregivers provisions modifications and increasing patient and cannabis plant limits expansion provisionIntroduced
- HF3615Cannabis laboratory testing requirements extended.Passed
- SF4877Cannabis license application periods and issuance modificationIntroduced
- SF4871Remediated cannabis product definitionIntroduced
- SF4876Cannabis microbusiness outdoor cultivation limit increaseIntroduced
- HF4733Remediated cannabis product defined, and cannabis business required to disclose information related to remediated cannabis products.Introduced
- SF4875Medical cannabis endorsement requirements modificationIntroduced
- HF4688Cannabis license holders allowed to transport products to testing facilities.Introduced
- HF4577Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.Introduced
- HF4570Cannabis microbusiness outdoor cultivation limit increased.Introduced
- SF4542Cannabis event provisions modificationIntroduced
LEGISLATIVE DATA PROVIDED BY LEGISCAN · LICENSED UNDER CC BY 4.0 · UPDATED Aug 17, 2026